Gilead, US government set for courtroom showdown over PrEP drug patents

Jury selection begins today in the U.S.' patent case against Gilead in Delaware federal court, according to a judge's order from late last week. The sides will present their cases at both a jury trial and at a bench trial, according to the order. In a bench trial, lawyers argue in front of a judge rather than a jury.